Bronchiectasis secondary prevention

Jump to navigation Jump to search

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis secondary prevention

CDC on Bronchiectasis secondary prevention

Bronchiectasis secondary prevention in the news

Blogs on Bronchiectasis secondary prevention

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis secondary prevention

Overview

To reduce the impact of the disease, patients should lead a healthy lifestyle, use prophylactic treatment when needed, do vaccinations, and practice physiotherapy strategies.

Bronchiectasis Secondary Prevention

Healthy Lifestyle

  • Smoking cessation
  • Exercise
  • Maintain a healthy BMI

Prophylactic Treatment

  • National guidelines recommend that patients suffering from three or more exacerbations per year, should be considered for long-term antibiotics.[1]
  • Macrolide daily or three times weekly
  • Amoxicillin 500 mg twice daily or doxycycline 100 mg twice daily for patients who are not candidates for long-term macrolide administration

Vaccination

  • There has been some evidence to support that the yearly influenza vaccine reduces morbidity, mortality, and healthcare costs with high-risk patients

Physiotherapy Strategies

  • Airway Clearance
  • Postural Drainage
  • Autogenic Drainage
  • Active Cycle of Breathing Techniques
  • Positive Expiratory Pressure (PEP)
  • Oscillatory PEP devices
  • High-frequency chest wall percussion
  • Pulmonary Rehabilitation
  • Exercise training
  • Nutritional counseling
  • Educationof the patient's disease and how to manage it
  • Techniques on how to conserve energy
  • Strategies on breathing
  • Psychological counseling

References

  1. 1.0 1.1 McDonnell MJ, Ward C, Lordan JL, Rutherford RM (2013). "Non-cystic fibrosis bronchiectasis". QJM. 106 (8): 709–15. doi:10.1093/qjmed/hct109. PMID 23728208.

Template:WH Template:WS